JW Holdings Corporation (096760.KS)
KRW 3050.0
(-0.65%)
KRW 3050.0
(-0.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 480.68 Billion KRW | -2.21% |
| 2022 | 491.54 Billion KRW | 11.49% |
| 2021 | 440.89 Billion KRW | -11.72% |
| 2020 | 499.46 Billion KRW | 3.97% |
| 2019 | 480.41 Billion KRW | -7.0% |
| 2018 | 516.56 Billion KRW | -25.01% |
| 2017 | 688.81 Billion KRW | 11.88% |
| 2016 | 615.67 Billion KRW | -2.78% |
| 2015 | 633.27 Billion KRW | -2.68% |
| 2014 | 650.72 Billion KRW | 3.83% |
| 2013 | 626.73 Billion KRW | -5.43% |
| 2012 | 662.69 Billion KRW | 3.43% |
| 2011 | 640.72 Billion KRW | 15.84% |
| 2010 | 553.11 Billion KRW | 46.26% |
| 2009 | 378.18 Billion KRW | 30.9% |
| 2008 | 288.9 Billion KRW | 27.42% |
| 2007 | 226.72 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 443.6 Billion KRW | -7.71% |
| 2024 Q2 | 439.03 Billion KRW | -1.03% |
| 2023 Q4 | 480.68 Billion KRW | -8.28% |
| 2023 Q3 | 524.08 Billion KRW | -3.05% |
| 2023 Q2 | 540.59 Billion KRW | 4.23% |
| 2023 FY | 480.68 Billion KRW | -2.21% |
| 2023 Q1 | 518.67 Billion KRW | 5.52% |
| 2022 Q2 | 472.84 Billion KRW | 2.36% |
| 2022 Q3 | 454.54 Billion KRW | -3.87% |
| 2022 Q4 | 491.54 Billion KRW | 8.14% |
| 2022 Q1 | 461.96 Billion KRW | 4.78% |
| 2022 FY | 491.54 Billion KRW | 11.49% |
| 2021 FY | 440.89 Billion KRW | -11.72% |
| 2021 Q3 | 433.91 Billion KRW | -6.04% |
| 2021 Q2 | 461.8 Billion KRW | 2.43% |
| 2021 Q1 | 450.86 Billion KRW | -9.73% |
| 2021 Q4 | 440.89 Billion KRW | 1.61% |
| 2020 Q4 | 499.46 Billion KRW | 7.2% |
| 2020 Q1 | 474.63 Billion KRW | -1.2% |
| 2020 FY | 499.46 Billion KRW | 3.97% |
| 2020 Q2 | 472.57 Billion KRW | -0.43% |
| 2020 Q3 | 465.89 Billion KRW | -1.41% |
| 2019 Q1 | 491.34 Billion KRW | -4.88% |
| 2019 Q3 | 487.75 Billion KRW | -5.11% |
| 2019 FY | 480.41 Billion KRW | -7.0% |
| 2019 Q2 | 514.01 Billion KRW | 4.62% |
| 2019 Q4 | 480.41 Billion KRW | -1.51% |
| 2018 Q4 | 516.56 Billion KRW | -5.97% |
| 2018 Q3 | 549.36 Billion KRW | 12.39% |
| 2018 Q2 | 488.78 Billion KRW | -26.72% |
| 2018 Q1 | 667.01 Billion KRW | -3.17% |
| 2018 FY | 516.56 Billion KRW | -25.01% |
| 2017 Q2 | 688.73 Billion KRW | 0.41% |
| 2017 Q4 | 688.81 Billion KRW | 1.75% |
| 2017 FY | 688.81 Billion KRW | 11.88% |
| 2017 Q3 | 676.99 Billion KRW | -1.7% |
| 2017 Q1 | 685.89 Billion KRW | 11.41% |
| 2016 Q3 | 657.08 Billion KRW | 5.56% |
| 2016 FY | 615.67 Billion KRW | -2.78% |
| 2016 Q1 | 566.75 Billion KRW | -10.5% |
| 2016 Q4 | 615.67 Billion KRW | -6.3% |
| 2016 Q2 | 622.49 Billion KRW | 9.83% |
| 2015 Q4 | 633.27 Billion KRW | -1.35% |
| 2015 FY | 633.27 Billion KRW | -2.68% |
| 2015 Q3 | 641.91 Billion KRW | -1.91% |
| 2015 Q2 | 654.39 Billion KRW | 1.62% |
| 2015 Q1 | 643.93 Billion KRW | -1.04% |
| 2014 Q4 | 650.72 Billion KRW | 0.18% |
| 2014 Q3 | 649.56 Billion KRW | -0.77% |
| 2014 FY | 650.72 Billion KRW | 3.83% |
| 2014 Q1 | 643.47 Billion KRW | 2.67% |
| 2014 Q2 | 654.62 Billion KRW | 1.73% |
| 2013 Q3 | 600.06 Billion KRW | 0.54% |
| 2013 Q4 | 626.73 Billion KRW | 4.44% |
| 2013 FY | 626.73 Billion KRW | -5.43% |
| 2013 Q1 | 671.04 Billion KRW | 1.26% |
| 2013 Q2 | 596.84 Billion KRW | -11.06% |
| 2012 FY | 662.69 Billion KRW | 3.43% |
| 2012 Q4 | 662.69 Billion KRW | 0.0% |
| 2011 Q3 | 16.73 Billion KRW | 21.6% |
| 2011 Q1 | 6.26 Billion KRW | 0.0% |
| 2011 Q2 | 13.75 Billion KRW | 119.46% |
| 2011 FY | 640.72 Billion KRW | 15.84% |
| 2010 Q3 | 65.37 Billion KRW | 6.07% |
| 2010 Q2 | 61.63 Billion KRW | 11.83% |
| 2010 Q1 | 55.11 Billion KRW | 0.0% |
| 2010 FY | 553.11 Billion KRW | 46.26% |
| 2009 Q3 | 31.38 Billion KRW | 50.58% |
| 2009 Q1 | 9.29 Billion KRW | 0.0% |
| 2009 FY | 378.18 Billion KRW | 30.9% |
| 2009 Q2 | 20.84 Billion KRW | 124.24% |
| 2008 Q1 | -1.01 Billion KRW | 0.0% |
| 2008 Q2 | 709.73 Million KRW | 169.74% |
| 2008 FY | 288.9 Billion KRW | 27.42% |
| 2008 Q3 | 349.27 Million KRW | -50.79% |
| 2007 Q3 | 4.98 Billion KRW | 0.0% |
| 2007 FY | 226.72 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Dongwha Pharm.Co.,Ltd | -24.06 Billion KRW | 2097.731% |
| Yuhan Corporation | -69.18 Billion KRW | 794.772% |
| Yuhan Corporation | -69.18 Billion KRW | 794.772% |
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -5360.966% |
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -5360.966% |
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -5360.966% |
| Ildong Holdings Co., Ltd. | 310.87 Billion KRW | -54.626% |
| Samil Pharmaceutical Co.,Ltd | 174.97 Billion KRW | -174.722% |
| Dong-A Socio Holdings Co., Ltd. | 572.02 Billion KRW | 15.967% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -211.384% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -211.384% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -211.384% |
| SAMSUNG PHARM. Co., LTD. | -3.68 Billion KRW | 13141.569% |
| Chong Kun Dang Holdings Corp. | 422.84 Billion KRW | -13.681% |
| Dong Sung Bio Pharm.Co.,Ltd. | 36.83 Billion KRW | -1204.893% |
| HANDOK Inc. | 283.45 Billion KRW | -69.582% |
| Jeil Pharma Holdings Inc | 135.99 Billion KRW | -253.469% |
| Kukje Pharma Co., Ltd. | 20.07 Billion KRW | -2294.798% |
| Bukwang Pharmaceutical Co., Ltd. | -71.84 Billion KRW | 769.108% |
| Aprogen pharmaceuticals,Inc. | 170.94 Billion KRW | -181.197% |
| Ilsung Pharmaceuticals Co., Ltd. | -159.84 Billion KRW | 400.717% |
| Daewon Pharmaceutical Co., Ltd. | 116.06 Billion KRW | -314.147% |
| Yungjin Pharm. Co., Ltd. | 59.67 Billion KRW | -705.521% |
| Boryung Corporation | 187.72 Billion KRW | -156.056% |
| Hyundai Pharmaceutical Co., Ltd. | 23 Billion KRW | -1989.817% |
| Samjin Pharmaceuticals Co., Ltd. | 116.23 Billion KRW | -313.543% |
| Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -535.203% |
| Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -535.203% |
| Suheung Co., Ltd. | 429.14 Billion KRW | -12.01% |
| Kwang Dong Pharmaceutical Co., Ltd. | 158.29 Billion KRW | -203.663% |
| Hanall Biopharma Co.,Ltd | -32.43 Billion KRW | 1582.145% |
| Whan In Pharm Co.,Ltd. | -44.73 Billion KRW | 1174.545% |
| MYUNGMOON Pharm co.,Ltd | 82.52 Billion KRW | -482.509% |
| Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -20343.339% |
| Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -20343.339% |
| Korea United Pharm Inc. | 16.42 Billion KRW | -2826.545% |
| CKD Bio Corp. | 143.29 Billion KRW | -235.451% |
| Daewoong pharmaceutical Co.,Ltd | 358.17 Billion KRW | -34.204% |
| REYON Pharmaceutical Co., Ltd. | 200.94 Billion KRW | -139.212% |
| Hanmi Pharm. Co., Ltd. | 517.88 Billion KRW | 7.183% |
| Dong-A ST Co., Ltd. | 193.95 Billion KRW | -147.841% |
| Chong Kun Dang Pharmaceutical Corp. | 117.53 Million KRW | -408886.77% |
| JW Lifescience Corporation | 26.09 Billion KRW | -1742.373% |
| Ildong Pharmaceutical Co., Ltd. | 164.58 Billion KRW | -192.065% |
| Jeil Pharmaceutical Co.,Ltd | 51.97 Billion KRW | -824.851% |
| Hana Pharm Co., Ltd. | 25.1 Billion KRW | -1814.451% |